ICU Medical ICUI EMEA — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ICU Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ICU Medical's emea — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ICU Medical's EMEA — revenue?
- ICU Medical (ICUI) reported EMEA — revenue of $104.68M in Q1 2026.
- How has ICU Medical's EMEA — revenue changed year-over-year?
- ICU Medical's EMEA — revenue increased by 9.4% year-over-year, from $95.69M to $104.68M.
- What is the long-term trend for ICU Medical's EMEA — revenue?
- Over 4 years (2021 to 2025), ICU Medical's EMEA — revenue has grown at a 29.3% compound annual growth rate (CAGR), from $147.49M to $411.68M.
- What does EMEA — revenue mean?
- This metric represents the total gross sales generated from products and services sold within the Europe, Middle East, and Africa geographic region. It serves as a key indicator of the company's market penetration, regional demand, and competitive positioning within these specific international healthcare markets. Tracking this revenue stream helps investors assess the success of regional sales strategies and the impact of global expansion efforts on the company's consolidated top-line performance.